These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2665087)

  • 1. Ticlopidine in the treatment of peripheral occlusive arterial disease.
    Arcan JC; Panak E
    Semin Thromb Hemost; 1989 Apr; 15(2):167-70. PubMed ID: 2665087
    [No Abstract]   [Full Text] [Related]  

  • 2. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound.
    Bernardi D; Bartoli P; Ferreri A; Geri AB; Ieri A
    Angiology; 1988 Nov; 39(11):942-52. PubMed ID: 3052183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A; Caspary L
    Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
    Boissel JP
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1721-4. PubMed ID: 1837446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract]   [Full Text] [Related]  

  • 15. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
    Heinrich F
    Fortschr Med; 1984 Sep; 102(36):74-5. PubMed ID: 6489898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years].
    MMW Fortschr Med; 2003 Apr; 145(15):63. PubMed ID: 15104272
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Katsumura T
    Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.